glp 1 and general anesthesia glp-1 guidance news Guidelines for peri-operative care of GLP-1 RA GIP patients 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations – Perioperative Considerations for Patients on

Side effects Note nausea, vomiting, or any new symptoms with the date and severity

Over 16 million Americans use GLP-1 medications for weight management, yet many delay treatment due to insurance barriers and high out-of-pocket costs

Key Takeaways Intestinal permeability is a regulated biological process studied in gastroenterology and immunology Leaky gut is a non-clinical term describing patterns linked to increased permeability The gut barrier is influenced by tight junctions, the mucus layer, microbes, and microbial metabolites Short-chain fatty acids (SCFAs) play a central role in barrier regulation Increased permeability is context-dependent and not always harmful Long-term gut barrier support focuses on regulation and resilience, not sealing the gut Why This Distinction Matters Confusing these terms can lead to: Fear-based health messaging Overdiagnosis Unsubstantiated treatment claims Science does not recognize leaky gut as a standalone disease

Metabolism regulation Assists in protein and fat metabolism

And its all NEW and ever-changing

(2022) Palmitoylethanolamide-based nutraceutical Calmux in preventive treatment of migraine